Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572
2018 ◽
Vol 124
(7)
◽
pp. 1455-1463
◽
David Schiff
◽
Kurt A. Jaeckle
◽
S. Keith Anderson
◽
Evanthia Galanis
◽
Caterina Giannini
◽
...
2019 ◽
Vol 125
(21)
◽
pp. 3790-3800
◽
Evanthia Galanis
◽
S. Keith Anderson
◽
Erin L. Twohy
◽
Xiomara W. Carrero
◽
Jesse G. Dixon
◽
...
Bruno Giometto
◽
Roberta Vitaliani
2011 ◽
Vol 29
(15_suppl)
◽
pp. 2033-2033
◽
K. A. Jaeckle
◽
D. Schiff
◽
S. K. Anderson
◽
E. Galanis
◽
P. J. Stella
◽
...
2008 ◽
Vol 26
(15_suppl)
◽
pp. 2024-2024
◽
K. A. Jaeckle
◽
W. Wu
◽
M. Kosel
◽
P. J. Flynn
◽
J. C. Buckner
2013 ◽
Vol 19
(17)
◽
pp. 4816-4823
◽
Evanthia Galanis
◽
S. Keith Anderson
◽
Jackie M. Lafky
◽
Joon H. Uhm
◽
Caterina Giannini
◽
...
2011 ◽
Vol 14
(2)
◽
pp. 215-221
◽
B. B. Friday
◽
S. K. Anderson
◽
J. Buckner
◽
C. Yu
◽
C. Giannini
◽
...
2001 ◽
Vol 28
(1B)
◽
pp. 4-8
◽
2010 ◽
Vol 21
(3)
◽
pp. 493-497
◽
W.W. Tan
◽
D.W. Hillman
◽
M. Salim
◽
D.W. Northfelt
◽
D.M. Anderson
◽
...
Close
Export Citation Format
Close
Share Document
Close